Kymera Therapeutics, Inc. demonstrates strong financial strength
Show original
As of December 31, 2025, the company holds cash reserves of up to $1.6 billions. This ample funding provides a solid guarantee for its future research and development as well as operations, and is expected to be sufficient to support the advancement of all business lines through 2029.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Tokens such as RED, HYPE, and ENA will face large unlocks next week
AIcoin•2026/03/01 12:16
Bitcoin March Historical Return: 6 Up Closes and 7 Down Closes since 2013, with an average return of 11.28%
BlockBeats•2026/03/01 12:15
Hyperliquid's February Revenue Surpasses $62 Million, Marking a 9.8% Decrease Month-on-Month
BlockBeats•2026/03/01 12:00
Odaily Evening News
Odaily星球日报•2026/03/01 11:32
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$66,507.6
+4.00%
Ethereum
ETH
$1,985.68
+6.33%
Tether USDt
USDT
$1
-0.01%
BNB
BNB
$622.35
+4.51%
XRP
XRP
$1.38
+6.34%
USDC
USDC
$0.9999
-0.05%
Solana
SOL
$85.24
+7.89%
TRON
TRX
$0.2810
+0.58%
Dogecoin
DOGE
$0.09358
+5.14%
Cardano
ADA
$0.2784
+5.76%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now